Core Laboratories Inc.
NLFinancials
Valuation Metrics
Core Laboratories Inc.'s Market Cap is $490M. At end of 2025 it was $745M. Ranked #2796 of 3,114 in US market (top 90%), #1568 of 1,645 on NYSE (top 95%), #162 of 168 in Energy (top 96%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $490M | US#2,796/3,114 Sec#162/168 |
| Revenue | $519M | US#2,211/3,114 Sec#145/168 |
| Net Income | $24M | US#2,064/3,114 Sec#129/168 |
| Total Assets | $587M | US#2,700/3,114 Sec#168/168 |
| Net Assets | $273M | US#2,558/3,114 Sec#160/168 |
| Employees | 3,300 | US#1,427/3,114 Sec#63/168 |
| Value | ||
| P/E | 20.10x | US#966/3,114 Sec#82/168 |
| P/B | 1.80x | US#982/3,114 Sec#61/168 |
| P/S | 0.94x | US#591/3,114 Sec#33/168 |
| EV/EBITDA | 10.09x | US#677/3,114 Sec#91/168 |
| FCF Yield | 2.19% | US#1,941/3,114 Sec#121/168 |
| Profitability | ||
| ROE | 8.93% | US#1,490/3,114 Sec#104/168 |
| ROA | 4.15% | US#1,198/3,114 Sec#94/168 |
| Op. Margin | 9.25% | US#1,639/3,114 Sec#119/168 |
| Revenue Growth | 0.35% | US#2,181/3,114 Sec#131/168 |
| Earnings Growth | -17.81% | US#1,510/3,114 Sec#95/168 |
| Financial Health | ||
| Debt Ratio | 112.96% | US#1,208/3,114 Sec#81/168 |
| Total Debt | $165M | US#2,303/3,114 Sec#153/168 |
| FCF | $11M | US#2,231/3,114 Sec#135/168 |
| Cash | $23M | US#2,831/3,114 Sec#153/168 |
| Current Ratio | 2.12x | US#1,163/3,114 Sec#50/168 |
| Net Debt/EBITDA | 2.27x | US#1,402/3,114 Sec#107/168 |
| Dividend | ||
| Div. Yield | 0.38% | US#1,563/3,114 Sec#127/168 |
| Div. Growth | 0.50% | US#1,187/3,114 Sec#75/168 |
| Payout Ratio | 5.88% | US#2/3,114 Sec#1/168 |
| Performance | ||
| 1Y Return | -33.46% | US#2,535/3,114 Sec#156/168 |
| 1M Return | 9.48% | US#2,521/3,114 Sec#146/168 |
| From 52W High | -47.84% | US#2,714/3,114 Sec#160/168 |
| 1Y MDD | -52.21% | US#2,477/3,114 Sec#157/168 |
| Trading | ||
| Volume | 726,609 shares | US#1,646/3,114 Sec#107/168 |
| Trading Value | $8M | US#2,393/3,114 Sec#141/168 |
| Per Share | ||
| EPS | $0.53 | US#1,868/3,114 Sec#116/168 |
| BPS | $5.92 | US#2,193/3,114 Sec#131/168 |
Company Info
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.